Evidence map›Paper›PMID 41022583›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2025

Evolution of implantable cardioverter-defibrillator shock therapy in children in the era of optimized ICD programming and remote monitoring.

Robin A Bertels, Eric Boersma, Martijn D Zeggelaar, Sophie A F van Dongen, Arend D J Ten Harkel, Lieselot van Erven, Cynthia Smeding, Beatrijs Bartelds, Gert van den Berg, Ewout P Boesaard and 5 more

Abstract readMulticenter Study
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Robin A BertelsDepartment of Pediatric Cardiology, Willem-Alexander Children's Hospital-Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, Leiden 2300 RC, the Netherlands.ORCID 0000-0002-9179-7953
Eric BoersmaThorax Center, Department of Cardiology, Erasmus Medical Center, Cardiovascular Institute, Dr. Molewaterplein 40, Rotterdam, the Netherlands.ORCID 0000-0002-2559-7128
Martijn D ZeggelaarCardiovascular Institute, Department of Pediatric Cardiology, Erasmus Medical Center-Sophia Children's Hospital, Dr. Molewaterplein 40, Rotterdam, the Netherlands.
Sophie A F van DongenCardiovascular Institute, Department of Pediatric Cardiology, Erasmus Medical Center-Sophia Children's Hospital, Dr. Molewaterplein 40, Rotterdam, the Netherlands.
Arend D J Ten HarkelDepartment of Pediatric Cardiology, Willem-Alexander Children's Hospital-Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, Leiden 2300 RC, the Netherlands.
Lieselot van ErvenDepartment of Cardiology, Leiden University Medical Center, Albinusdreef 2, Leiden, the Netherlands.ORCID 0000-0003-3882-9941
Cynthia SmedingCardiovascular Institute, Department of Pediatric Cardiology, Erasmus Medical Center-Sophia Children's Hospital, Dr. Molewaterplein 40, Rotterdam, the Netherlands.
Beatrijs BarteldsCardiovascular Institute, Department of Pediatric Cardiology, Erasmus Medical Center-Sophia Children's Hospital, Dr. Molewaterplein 40, Rotterdam, the Netherlands.ORCID 0000-0003-3151-2474
Gert van den BergCardiovascular Institute, Department of Pediatric Cardiology, Erasmus Medical Center-Sophia Children's Hospital, Dr. Molewaterplein 40, Rotterdam, the Netherlands.ORCID 0000-0003-4093-8709
Ewout P BoesaardDepartment of Pediatric Cardiology, Radboud University Medical Center-Amalia Children's Hospital, Geert Grooteplein Zuid 10, Nijmegen, the Netherlands.ORCID 0009-0008-0948-2399
Rohit E BhagwandienThorax Center, Department of Cardiology, Erasmus Medical Center, Cardiovascular Institute, Dr. Molewaterplein 40, Rotterdam, the Netherlands.
Sing-Chien YapThorax Center, Department of Cardiology, Erasmus Medical Center, Cardiovascular Institute, Dr. Molewaterplein 40, Rotterdam, the Netherlands.ORCID 0000-0003-4520-2725
Reinoud E KnopsDepartment of Cardiology, Amsterdam University Medical Centers, Meibergdreef 9, Amsterdam, the Netherlands.ORCID 0000-0002-0772-3573
Nico A BlomDepartment of Pediatric Cardiology, Willem-Alexander Children's Hospital-Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, Leiden 2300 RC, the Netherlands.ORCID 0000-0002-4823-6974
Janneke A E KammeraadCardiovascular Institute, Department of Pediatric Cardiology, Erasmus Medical Center-Sophia Children's Hospital, Dr. Molewaterplein 40, Rotterdam, the Netherlands.ORCID 0000-0002-1556-9422

Funding

Dutch Hartekind Foundation
6 · The paper itself

Abstract

aimsImplantable cardioverter defibrillator (ICD) therapy is effective in preventing sudden cardiac death in children. Unnecessary shocks should be avoided. ICD programming strategies and remote monitoring have been proven to be effective in preventing ICD shock therapy in adults; the present study evaluates the effectiveness in children. METHODS AND

resultsRetrospective multi-centre study, including children with transvenous or epicardial ICD implantation. During follow-up data on ICD shocks, programming variables and remote monitoring were collected. One hundred sixteen children were included, median age 13.4 years (min-max 0.3-18) and median follow-up 5.2 years (IQR 3.7-6.6), 53 with an ICD implanted before 2010 and 63 after 2010. The total appropriate and inappropriate annual shock rate decreased from 10.5 to 8% [difference in mean cumulative function (MCF) P = 0.008], 7.8 to 5.8% (MCF P = 0.036), and 4.3 to 2.6% (MCF P = 0.28), respectively, without increase in cardiac-related death. Remote monitoring was associated with a decrease of total shocks (MCF P = 0.013) and appropriate shocks (MCF P = 0.052). The ventricular fibrillation (VF) zone was programmed higher (≥210 bpm) at the time of appropriate vs. inappropriate shocks (86 vs. 79%; P = 0.0016), with no significant change in VF zone programming after 2010 compared to before 2010 (90 vs. 76%; P = 0.142) and in patients with vs. without shocks (79 vs. 89%; P = 0.243).

conclusionThe incidence of ICD shocks has significantly decreased in children with implantation after 2010, which appears to be multifactorial. A changed programming behaviour and remote monitoring are associated with this decrease and support its use in strategies to prevent unnecessary shocks in children.

Indexed as

Death, Sudden, CardiacDefibrillators, ImplantableElectric CountershockRemote Sensing TechnologyAdolescentChildChild, PreschoolFemaleHumansInfantMaleRetrospective StudiesRisk FactorsTime FactorsTreatment OutcomeChildrenICD programmingImplantable cardioverter–defibrillatorRemote monitoringVF zone

Identifiers

PMID41022583
PMCPMC12525143

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.